Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novartis discloses Janus kinase inhibitors

June 15, 2017

Chiesi Farmaceutici discloses muscarinic M3 receptor antagonists and beta2-adrenoceptor agonists

June 15, 2017

Cancer Research Technology and AstraZeneca divulge GLS inhibitors

June 15, 2017

Adaptimmune and Immunocore identify TRPM1 derivatives

June 15, 2017

Leids Universitair Medisch Centrum presents recombinant serine protease variants

June 15, 2017

Genentech and Xenon Pharmaceuticals disclose Nav1.7 channel blockers

June 14, 2017

Ohara Pharmaceutical discloses prodrugs of azacytidine and decitabine

June 14, 2017

AbbVie discovers 5-HT2C receptor agonists

June 14, 2017

Leo Pharma patents 3-triazolo-3-deoxy-ingenol derivatives

June 14, 2017

Jiangsu Chia Tai Tianqing Pharmaceutical Group presents ALK inhibitors

June 14, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...